BIONXT SOLUTIONS INC (BNXTF) analyst actions
Rating and price-target actions on BNXTF in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the BNXTF overview →
2 measured BNXTF analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| BioNxt Advances Sublingual Everolimus ODF for Organ Transplant Rejection with Initiation of Large-Animal Pharmacokinetic Study | Press release | +0.00% | +0.00% | |
| BioNxt Initiates GMP Manufacturing of Clinical-Grade Sublingual Cladribine Film Targeting Multiple Sclerosis (MS) | Press release | +0.00% | +19.59% |
Keep exploring
More BNXTF: earnings → · SEC filings → · BNXTF overview →